CD274 and non-small cell lung carcinoma: Other studies have shown that non-small cell lung cancer patients who received cisplatin-based neoadjuvant chemotherapy followed by surgery have significantly increased PD-L1 expression in both tumor cells and immune cells from the microenvironment [30].